Page last updated: 2024-10-26

doxepin and Day Blindness

doxepin has been researched along with Day Blindness in 2 studies

Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rickels, K1
Feighner, JP1
Smith, WT1
Pigott, PV1

Trials

2 trials available for doxepin and Day Blindness

ArticleYear
Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression.
    Archives of general psychiatry, 1985, Volume: 42, Issue:2

    Topics: Adult; Alcoholism; Alprazolam; Ambulatory Care; Amitriptyline; Anti-Anxiety Agents; Benzodiazepines;

1985
A review of clinical studies with combinations of fluphenazine and nortriptyline.
    Current medical research and opinion, 1972, Volume: 1, Issue:1

    Topics: Amitriptyline; Anxiety; Central Nervous System; Clinical Trials as Topic; Depression; Diazepam; Doxe

1972